S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Dolby Laboratories Stock Forecast, Price & News

-0.84 (-0.97%)
(As of 11/26/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
254,377 shs
Average Volume
417,947 shs
Market Capitalization
$8.71 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive DLB News and Ratings via Email

Sign-up to receive the latest news and ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Dolby Laboratories logo

About Dolby Laboratories

Dolby Laboratoties, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries. Its products include Cinema Imaging, Cinema Audio, Dolby Conference Phone, Dolby Voice Room, and Other Products. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.


See More Headlines

Industry, Sector and Symbol

Patent owners & lessors
Electronic Components
Year Founded

Sales & Book Value

Annual Sales
$1.28 billion
Cash Flow
$4.23 per share
Book Value
$25.69 per share


Net Income
$310.23 million
Pretax Margin




Free Float
Market Cap
$8.71 billion

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

2.79 out of 5 stars

Consumer Discretionary Sector

36th out of 389 stocks

Patent Owners & Lessors Industry

3rd out of 12 stocks

Analyst Opinion: 2.4Community Rank: 3.9Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -

Dolby Laboratories (NYSE:DLB) Frequently Asked Questions

Is Dolby Laboratories a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Dolby Laboratories stock.
View analyst ratings for Dolby Laboratories
or view top-rated stocks.

How has Dolby Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Dolby Laboratories' stock was trading at $60.23 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DLB stock has increased by 42.6% and is now trading at $85.90.
View which stocks have been most impacted by COVID-19

When is Dolby Laboratories' next earnings date?

Dolby Laboratories is scheduled to release its next quarterly earnings announcement on Thursday, January 27th 2022.
View our earnings forecast for Dolby Laboratories

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories, Inc. (NYSE:DLB) released its quarterly earnings data on Tuesday, November, 16th. The electronics maker reported $0.58 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.56 by $0.02. The electronics maker earned $285.03 million during the quarter, compared to the consensus estimate of $299.95 million. Dolby Laboratories had a net margin of 24.21% and a trailing twelve-month return on equity of 11.87%. The company's revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.28 EPS.
View Dolby Laboratories' earnings history

How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?

Dolby Laboratories declared a quarterly dividend on Tuesday, November 16th. Investors of record on Tuesday, November 30th will be paid a dividend of $0.25 per share on Wednesday, December 8th. This represents a $1.00 annualized dividend and a yield of 1.16%. The ex-dividend date is Monday, November 29th. This is an increase from Dolby Laboratories's previous quarterly dividend of $0.22.
View Dolby Laboratories' dividend history

Is Dolby Laboratories a good dividend stock?

Dolby Laboratories pays an annual dividend of $0.88 per share and currently has a dividend yield of 1.01%. Dolby Laboratories does not yet have a strong track record of dividend growth. The dividend payout ratio of Dolby Laboratories is 29.63%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 24.31% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.
View Dolby Laboratories' dividend history.

What guidance has Dolby Laboratories issued on next quarter's earnings?

Dolby Laboratories updated its FY 2022 earnings guidance on Tuesday, November, 23rd. The company provided earnings per share (EPS) guidance of $3.520-$4.020 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.940. The company issued revenue guidance of $1.34 billion-$1.40 billion, compared to the consensus revenue estimate of $1.37 billion.

What price target have analysts set for DLB?

4 brokerages have issued 12-month price objectives for Dolby Laboratories' stock. Their forecasts range from $89.00 to $114.00. On average, they anticipate Dolby Laboratories' stock price to reach $101.50 in the next twelve months. This suggests a possible upside of 18.2% from the stock's current price.
View analysts' price targets for Dolby Laboratories
or view top-rated stocks among Wall Street analysts.

Who are Dolby Laboratories' key executives?

Dolby Laboratories' management team includes the following people:
  • Kevin J. Yeaman, President, Chief Executive Officer & Director
  • Robert J. Park, Chief Financial Officer & Senior Vice President
  • Steven E. Forshay, Senior Vice President-Advanced Technology Group
  • Mark Andrew Sherman, Secretary, Executive VP & General Counsel
  • Todd Pendleton, Chief Marketing Officer & Senior Vice President

What is Kevin J. Yeaman's approval rating as Dolby Laboratories' CEO?

253 employees have rated Dolby Laboratories CEO Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among Dolby Laboratories' employees.

Who are some of Dolby Laboratories' key competitors?

Some companies that are related to Dolby Laboratories include Amphenol (APH), Corning (GLW), Littelfuse (LFUS), Rogers (ROG) and Vishay Intertechnology (VSH).
View all of DLB's competitors

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

What is Dolby Laboratories' stock symbol?

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Who are Dolby Laboratories' major shareholders?

Dolby Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.67%), Janus Henderson Group PLC (2.08%), Mackenzie Financial Corp (1.42%), Bank of New York Mellon Corp (1.29%), Invesco Ltd. (1.10%) and Polar Capital Holdings Plc (1.05%). Company insiders that own Dolby Laboratories stock include Avadis Tevanian, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Ryan Nicholson, Steven E Forshay and Todd Pendleton.
View institutional ownership trends for Dolby Laboratories

Which major investors are selling Dolby Laboratories stock?

DLB stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Goldman Sachs Group Inc., William Blair Investment Management LLC, Arrowstreet Capital Limited Partnership, Janus Henderson Group PLC, Sunriver Management LLC, Two Sigma Advisers LP, and BlackRock Inc.. Company insiders that have sold Dolby Laboratories company stock in the last year include Avadis Tevanian, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Ryan Nicholson, Steven E Forshay, and Todd Pendleton.
View insider buying and selling activity for Dolby Laboratories
or view top insider-selling stocks.

Which major investors are buying Dolby Laboratories stock?

DLB stock was purchased by a variety of institutional investors in the last quarter, including Marathon Asset Mgmt Ltd, Ceredex Value Advisors LLC, Jupiter Asset Management Ltd., Bank of New York Mellon Corp, Ninety One UK Ltd, Allianz Asset Management GmbH, Ararat Capital Management LP, and Cubist Systematic Strategies LLC.
View insider buying and selling activity for Dolby Laboratories
or or view top insider-buying stocks.

How do I buy shares of Dolby Laboratories?

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dolby Laboratories' stock price today?

One share of DLB stock can currently be purchased for approximately $85.90.

How much money does Dolby Laboratories make?

Dolby Laboratories has a market capitalization of $8.71 billion and generates $1.28 billion in revenue each year. The electronics maker earns $310.23 million in net income (profit) each year or $2.97 on an earnings per share basis.

How many employees does Dolby Laboratories have?

Dolby Laboratories employs 2,368 workers across the globe.

Does Dolby Laboratories have any subsidiaries?

The following companies are subsidiares of Dolby Laboratories: Coding Technologies, Dolby International AB, Dolby Laboratories Licensing Corporation, Doremi Labs, Step Labs, and Voxeet.

When was Dolby Laboratories founded?

Dolby Laboratories was founded in 1965.

What is Dolby Laboratories' official website?

The official website for Dolby Laboratories is www.dolby.com.

Where are Dolby Laboratories' headquarters?

Dolby Laboratories is headquartered at 1275 MARKET STREET, SAN FRANCISCO CA, 94103.

How can I contact Dolby Laboratories?

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at (415) 558-0200, via email at [email protected], or via fax at 415-645-4000.

This page was last updated on 11/27/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.